Genome BC

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Genome British Columbia and Genome Canada today announced nearly C$4.3million (US$4.3 million) in funding for the development of genomic diagnostics aimed at forest disease.

The program, jointly funded by the Canadian government, will support testing of genomics tools and innovations in a real-world setting.

The goal is to analyze a variety of genomic techniques, including sequencing, to develop a test that will determine whether AML patients should receive chemotherapy or stem cell transplantation.

The Genome British Columbia program will kick off with funding totaling around $9 million for three personalized medicine studies.

The Canadian genomics research group will develop resources for cre-recombinase for use in mutagenesis-based research into human diseases.

Pages

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.

Retraction Watch's Ivan Oransky and Adam Marcus report that Harvard Medical School and Brigham and Women's Hospital have recommended that more than 30 papers from a former researcher be retracted.

Thomas Steitz, who won the 2009 chemistry Nobel Prize for his ribosome work, has died, the Washington Post reports.

In PLOS this week: mechanisms for genes implicated in coronary artery disease, rumen microbes and host genetics influence cow methane production, and more.